Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma

Patients with advanced hepatocellular carcinoma (HCC) showing portal vein tumor thrombosis (PVTT) have an extremely poor prognosis. According to treatment guidelines, the only option for HCC patients with PVTT is sorafenib chemotherapy. However, in Asia, various treatments have been attempted and po...

Descripción completa

Detalles Bibliográficos
Autores principales: Takano, Michitoshi, Kokudo, Takashi, Miyazaki, Yoshihiro, Kageyama, Yumiko, Takahashi, Amane, Amikura, Katsumi, Sakamoto, Hirohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107709/
https://www.ncbi.nlm.nih.gov/pubmed/27895433
http://dx.doi.org/10.3748/wjg.v22.i42.9445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107709/
https://www.ncbi.nlm.nih.gov/pubmed/27895433
http://dx.doi.org/10.3748/wjg.v22.i42.9445

Ejemplares similares